The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential - PubMed (original) (raw)
The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential
Zhao Zhong Chong et al. J Cereb Blood Flow Metab. 2004 Jul.
Abstract
Nicotinamide, a beta-nicotinamide adenine dinucleotide (NAD) precursor and an essential nutrient for cell growth and function, may offer critical insights into the specific cellular mechanisms that determine neuronal survival, since this agent significantly impacts upon both neuronal and vascular integrity in the central nervous system. The authors show that nicotinamide provides broad, but concentration-specific, protection against apoptotic genomic DNA fragmentation and membrane phosphatidylserine exposure during oxidative stress to secure cellular integrity and prevent phagocytic cellular demise. Activation of the protein kinase B (Akt1) pathway is a necessary requirement for nicotinamide protection, because transfection of primary hippocampal neurons with a plasmid encoding a kinase-deficient dominant-negative Akt1 as well as pharmacologic inhibition of phosphatidylinositol-3-kinase phosphorylation of Akt1 eliminates cytoprotection by nicotinamide. Nicotinamide fosters neuronal survival through a series of intimately associated pathways. At one level, nicotinamide directly modulates mitochondrial membrane potential and pore formation to prevent cytochrome c release and caspase-3-and 9-like activities through mechanisms that are independent of the apoptotic protease activating factor-1. At a second level, nicotinamide maintains an inhibitory phosphorylation of the forkhead transcription factor FOXO3a at the regulatory sites of Thr and Ser and governs a unique regulatory loop that prevents the degradation of phosphorylated FOXO3a by caspase-3. Their work elucidates some of the unique neuro-protective pathways used by the essential cellular nutrient nicotinamide that may direct future therapeutic approaches for neurodegenerative disorders.
Similar articles
- Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation.
Kang JQ, Chong ZZ, Maiese K. Kang JQ, et al. Mol Pharmacol. 2003 Sep;64(3):557-69. doi: 10.1124/mol.64.3.557. Mol Pharmacol. 2003. PMID: 12920191 - Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
Chong ZZ, Lin SH, Kang JQ, Maiese K. Chong ZZ, et al. J Neurosci Res. 2003 Mar 1;71(5):659-69. doi: 10.1002/jnr.10528. J Neurosci Res. 2003. PMID: 12584724 - AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9.
Chong ZZ, Kang JQ, Maiese K. Chong ZZ, et al. Exp Cell Res. 2004 Jun 10;296(2):196-207. doi: 10.1016/j.yexcr.2004.01.021. Exp Cell Res. 2004. PMID: 15149850 - Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain.
Maiese K, Chong ZZ. Maiese K, et al. Trends Pharmacol Sci. 2003 May;24(5):228-32. doi: 10.1016/S0165-6147(03)00078-6. Trends Pharmacol Sci. 2003. PMID: 12767721 Review. - Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system.
Chong ZZ, Maiese K. Chong ZZ, et al. Histol Histopathol. 2004 Apr;19(2):495-504. doi: 10.14670/HH-19.495. Histol Histopathol. 2004. PMID: 15024710 Free PMC article. Review.
Cited by
- Novel avenues of drug discovery and biomarkers for diabetes mellitus.
Maiese K, Chong ZZ, Shang YC, Hou J. Maiese K, et al. J Clin Pharmacol. 2011 Feb;51(2):128-52. doi: 10.1177/0091270010362904. Epub 2010 Mar 10. J Clin Pharmacol. 2011. PMID: 20220043 Free PMC article. Review. - Pre-B-cell colony-enhancing factor exerts a neuronal protection through its enzymatic activity and the reduction of mitochondrial dysfunction in in vitro ischemic models.
Bi J, Li H, Ye SQ, Ding S. Bi J, et al. J Neurochem. 2012 Jan;120(2):334-46. doi: 10.1111/j.1471-4159.2011.07566.x. Epub 2011 Nov 24. J Neurochem. 2012. PMID: 22044451 Free PMC article. - Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling.
Hung CH, Chan SH, Chu PM, Lin HC, Tsai KL. Hung CH, et al. Oncotarget. 2016 Mar 8;7(10):10773-87. doi: 10.18632/oncotarget.7387. Oncotarget. 2016. PMID: 26885898 Free PMC article. - Novel directions for diabetes mellitus drug discovery.
Maiese K, Chong ZZ, Shang YC, Wang S. Maiese K, et al. Expert Opin Drug Discov. 2013 Jan;8(1):35-48. doi: 10.1517/17460441.2013.736485. Epub 2012 Oct 24. Expert Opin Drug Discov. 2013. PMID: 23092114 Free PMC article. Review. - Diabetes mellitus: channeling care through cellular discovery.
Maiese K, Shang YC, Chong ZZ, Hou J. Maiese K, et al. Curr Neurovasc Res. 2010 Feb;7(1):59-64. doi: 10.2174/156720210790820217. Curr Neurovasc Res. 2010. PMID: 20158461 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous